(Q44245391)

1 December 2017

title

Increased levels of osteoprotegerin in hemodialysis patients (English)

1 reference

1 December 2017

4

1 reference

1 December 2017

author name string

Ivica Avbersek-Luznik

series ordinal

1

1 reference

1 December 2017

Ivan Malesic

series ordinal

2

1 reference

1 December 2017

Igor Rus

series ordinal

3

1 reference

1 December 2017

publication date

1 October 2002

1 reference

Clinical Chemistry and Laboratory Medicine

1 December 2017

published in

1 reference

1 December 2017

volume

40

1 reference

1 December 2017

issue

10

1 reference

1 December 2017

page(s)

1019-1023

1 reference

Regulation of bone cell development and function: implication for renal osteodystrophy.

1 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2002.177

Osteoprotegerin: a novel secreted protein involved in the regulation of bone density

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2002.177

Isolation of a novel cytokine from human fibroblasts that specifically inhibits osteoclastogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2002.177

The effect of a single dose of osteoprotegerin in postmenopausal women

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2002.177

Osteoprotegerin and parathyroid hormone as markers of high-turnover osteodystrophy and decreased bone mineralization in hemodialysis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2002.177

Parathyroid hormone stimulates TRANCE and inhibits osteoprotegerin messenger ribonucleic acid expression in murine bone marrow cultures: correlation with osteoclast-like cell formation

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2002.177

A chimeric form of osteoprotegerin inhibits hypercalcemia and bone resorption induced by IL-1beta, TNF-alpha, PTH, PTHrP, and 1, 25(OH)2D3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2002.177

Serum osteoprotegerin and renal osteodystrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2002.177

Increased serum osteoprotegerin in disorders characterized by persistent immune activation or glucocorticoid excess--possible role in bone homeostasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2002.177

Immunological characterization of circulating osteoprotegerin/osteoclastogenesis inhibitory factor: increased serum concentrations in postmenopausal women with osteoporosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2002.177

Identity of osteoclastogenesis inhibitory factor (OCIF) and osteoprotegerin (OPG): a mechanism by which OPG/OCIF inhibits osteoclastogenesis in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2002.177

Characterization of a novel TNF-like ligand and recently described TNF ligand and TNF receptor superfamily genes and their constitutive and inducible expression in hematopoietic and non-hematopoietic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2002.177

21 January 2018

Identifiers

DOI

10.1515/CCLM.2002.177

1 reference

1 December 2017

1 reference